Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,370.00
Bid: 12,370.00
Ask: 12,374.00
Change: 38.00 (0.31%)
Spread: 4.00 (0.032%)
Open: 12,350.00
High: 12,432.00
Low: 12,314.00
Prev. Close: 12,332.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-German minister sees COVID-19 vaccine shortage well into April

Thu, 28th Jan 2021 08:55

* Health minister: vaccine shortages to last at least 10
weeks

* Interior ministry preparing entry ban for risk countries

* 7-day incidence falls below 100 cases/100,000 people
(Adds details on incidence, entry ban)

BERLIN, Jan 28 (Reuters) - Germany faces a shortage of
coronavirus shots well into April, its health minister said on
Thursday, and called for a summit with the country's state
leaders to discuss vaccinations as the government faced fresh
criticism over the pace of the roll-out.

"We will still have at least 10 tough weeks with a shortage
of vaccine," Jens Spahn said in a Tweet, adding the meeting
should focus on how Europe gets its fair share of shots and what
can be done to support the process.

A spokesman for Chancellor Angela Merkel said she backed the
proposal and planning for the summit was already underway.

On Thursday, Germany's top-selling Bild newspaper described
the problem of procuring enough vaccines as a "scandal," while a
poll for the Frankfurter Allgemeine Zeitung said approval for
the government's coronavirus policy had fallen to 49%, its
lowest level since the pandemic began.

Spahn said he wanted to invite pharmaceutical companies and
vaccine manufacturers to a meeting to discuss the way forward,
adding he recognised vaccine production was complex and
production could not be built up in a few weeks.

On Tuesday, Spahn supported European Union proposals to set
up a register of vaccine exports, as tensions grow with
AstraZeneca and Pfizer over sudden supply cuts
just a month after the EU started vaccinating citizens.

Germany reported 17,553 new coronavirus cases on Thursday,
bringing the total to 2,178,828, and another 941 deaths. The
seven-day incidence rate fell under 100 cases per 100,000 for
the first time since the end of October. The government wants it
to drop below 50.

Spahn has said that if cases continue to fall, schools and
nurseries should be the first to reopen after a lockdown
currently due to last until Feb. 14.

Germany is also preparing entry restrictions for travellers
from Britain, Brazil and South Africa, the interior ministry
said, and hopes to decide by Friday as concerns mount about more
contagious variants.

"We have to get ahead of the situation," Interior Minister
Horst Seehofer said on Twitter.
(Reporting by Emma Thomasson, Caroline Copley and Andreas
Rinke; Editing by Thomas Seythal, Alex Richardson and Giles
Elgood)

More News
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.